MARKET

XBI

XBI

State Street® SPDR® S&P® Biotech ETF
NYSEARCA
145.04
-0.24
-0.17%
After Hours: 145.35 +0.31 +0.21% 19:55 11/18 EST
OPEN
144.86
PREV CLOSE
145.28
HIGH
147.61
LOW
144.40
VOLUME
4.24M
TURNOVER
--
52 WEEK HIGH
169.89
52 WEEK LOW
112.58
TOTAL ASSET
9.70B
YTD YIELD
27.04%
1D
5D
1M
3M
1Y
5Y
1D
Biotech ETFs Brace for FDA Showdown: Two Drug Decisions Could Test Investor Sentiment
Benzinga · 2d ago
Weekly Report: what happened at XBI last week (1109-1113)?
Weekly Report · 2d ago
XBI, SYRE, EXEL, BIIB: ETF Outflow Alert
NASDAQ · 6d ago
Hims-Eli Lilly GLP-1 Deal Meets Summit’s FDA Gamble: Which Biotech ETFs Stand to Gain?
Benzinga · 11/09 16:51
Weekly Report: what happened at XBI last week (1102-1106)?
Weekly Report · 11/09 10:26
AI and Tech Selloff Heats Up: Buy Big Pharma Stock LLY as a Safe Haven?
NASDAQ · 11/05 21:27
Democrats Sweep Midterms: What It Means For Pharma And Biotech Holdings (Stocks To Watch)
Seeking Alpha · 11/05 17:09
Best Biotech Stocks to Buy Now as AI Stocks Tank: ARGX
NASDAQ · 11/04 21:42
More
Profile
Fund Name
State Street® SPDR® S&P® Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P Biotechnology Select Industry TR USD
Advisor Company
SPDR State Street Investment Management
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Emiliano Rabinovich, Raymond Donofrio, Karl Schneider